Have your own idea? Try our Stock Screener
UPDATED Nov 20, 2024
Explore the U.S. (NYSE and NASDAQ) Top Gainers Today. These Healthcare Stocks have seen the largest rise in Market Cap from the previous trading day.
| Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
SEM | US$38.09 | 2.9% | 61.4% | US$4.8b | US$45.40 | PE18.5x | E11.9% | 1.3% | ||
LH | US$237.85 | 0.7% | 12.4% | US$19.8b | US$261.25 | PE45.7x | E20.6% | 1.2% | ||
CON | US$21.26 | 4.9% | n/a | US$2.6b | US$28.00 | PE15.7x | E4.0% | 1.2% | ||
ESTA | US$41.81 | 11.4% | 66.4% | US$1.1b | US$60.29 | PS7.6x | E49.2% | n/a | ||
VEEV | US$210.63 | 0.4% | 19.9% | US$34.0b | US$250.11 | PE55.4x | E13.9% | n/a | ||
ONEM | US$16.47 | 2.9% | 68.8% | US$3.4b | US$18.00 | PS3.2x | E15.5% | n/a | ||
ALGN | US$223.87 | 0.6% | 3.0% | US$16.6b | US$261.24 | PE37.8x | E17.5% | n/a | ||
SMLR | US$59.27 | 27.9% | 60.4% | US$336.7m | US$40.00 | PE27.1x | n/a | n/a | ||
CHE | US$552.87 | 1.0% | -4.8% | US$8.2b | US$663.67 | PE27.4x | E8.8% | 0.4% | ||
PEN | US$239.20 | 0.9% | 3.2% | US$9.1b | US$234.07 | PE265.7x | E44.6% | n/a | ||
MASI | US$164.95 | 0.9% | 78.1% | US$8.8b | US$166.52 | PE112.4x | E29.6% | n/a | ||
UFPT | US$298.79 | 2.9% | 73.8% | US$2.2b | US$381.00 | PE42.3x | E16.9% | n/a | ||
BFLY | US$3.32 | 8.9% | 225.5% | US$705.7m | US$3.25 | PS9.3x | E17.6% | n/a | ||
BAX | US$32.63 | 0.3% | -9.0% | US$16.6b | US$40.52 | PE137.7x | E39.8% | 2.1% | ||
USPH | US$94.06 | 3.8% | 7.7% | US$1.4b | US$107.40 | PE100.7x | E29.4% | 1.9% | ||
ATEC | US$9.93 | 3.8% | -15.7% | US$1.4b | US$16.83 | PS2.5x | E58.0% | n/a | ||
UHS | US$197.52 | 0.4% | 42.7% | US$13.0b | US$246.08 | PE12.7x | E8.5% | 0.4% | ||
INMD | US$18.24 | 3.0% | -21.3% | US$1.5b | US$21.33 | PE10x | E7.5% | n/a | ||
NVCR | US$16.86 | 2.3% | 41.4% | US$1.8b | US$26.71 | PS3.2x | E4.2% | n/a | ||
VREX | US$15.42 | 5.9% | -22.0% | US$633.7m | US$22.20 | PB1.2x | E131.3% | n/a | ||
GMED | US$83.59 | 0.3% | 81.8% | US$11.3b | US$90.54 | PE124.4x | E48.3% | n/a | ||
CLOV | US$3.35 | 2.1% | 236.6% | US$1.6b | US$4.23 | PB4.9x | E61.5% | n/a | ||
AGL | US$1.67 | 5.0% | -85.9% | US$655.1m | US$3.63 | PB1.2x | E56.5% | n/a | ||
KIDS | US$25.50 | 4.9% | -19.8% | US$588.9m | US$40.67 | PS3.3x | E22.6% | n/a |